Cite
HARVARD Citation
Yu, M. et al. (2018). Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance. Artificial cells, nanomedicine, and biotechnology. pp. 323-332. [Online].